title: Psoriasis induced by anti-TNF probably not so uncommon.
authors.forename: Rosario Ibáñez
authors.initials: RI
authors.lastname: Bosch
authors.forename: Natividad del val del
authors.initials: Ndel V
authors.lastname: Amo
authors.forename: Concepción Fito
authors.initials: CF
authors.lastname: Manteca
authors.forename: Eduardo Loza
authors.initials: EL
authors.lastname: Cortina
authors.forename: Ricardo Gutierrez
authors.initials: RG
authors.lastname: Polo
authors.forename: Laura Garrido
authors.initials: LG
authors.lastname: Courel
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D006801:Humans; D000069285:Infliximab; D008297:Male; D011565:Psoriasis / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab